We are live on
!
Find out more
DMAAR
Drugs Made In America Acquisition Corp Rights
DMAAR
DMAAR
32 hedge funds and large institutions have $7.1M invested in Drugs Made In America Acquisition Corp Rights in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 2 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
220% more capital invested
Capital invested by funds: $2.22M → $7.1M (+$4.88M)
33% more funds holding
Funds holding: 24 → 32 (+8)
75% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 8
Holders
32
Holders Change
+8
Holders Change %
+33.33%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
2
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
26
Bulldog Investors
Saddle Brook,
New Jersey
| $28.3K | +$10.7K | +57,300 | +79% |
|
27
Verition Fund Management
Greenwich,
Connecticut
| $21.8K | – | – | – |
|
|
QL
28
Quarry LP
New York
| $21.7K | -$9.29K | -50,000 | -33% |
|
29
Parallax Volatility Advisers
San Francisco,
California
| $19.1K | +$16.3K | +87,926 | New |
|
|
PC
30
Periscope Capital
Toronto,
Ontario, Canada
| $16.3K | +$13.9K | +75,000 | New |
|
|
RAM
31
Readystate Asset Management
Chicago,
Illinois
| $10.9K | +$9.29K | +50,000 | New |
|
32
UBS Group
Zurich,
Switzerland
| $33 | +$28 | +150 | New |
|
|
CA
33
Crossingbridge Advisors
Pleasantville,
New York
| – | -$106K | -850,000 | Closed |
|
|
CF
34
Cantor Fitzgerald
New York
| – | -$60.1K | -500,000 | Closed |
|
|
MSU
35
Mizuho Securities USA
New York
| – | -$21K | -209,897 | Closed |
|